NEA Management Company’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

NEA Management Company’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-62,500	Closed	-$3.61M	–	66
2021 Q3	$3.61M	Hold	62,500	–	–	0.04%	58
2021 Q2	$3.02M	Hold	62,500	–	–	0.04%	58
2021 Q1	$4.4M	Hold	62,500	–	–	0.1%	54
2020 Q4	$5.77M	Hold	62,500	–	–	0.15%	52
2020 Q3	$3.75M	Hold	62,500	–	–	0.16%	45
2020 Q2	$5.72M	Hold	62,500	–	–	0.23%	38
2020 Q1	$3.34M	Hold	62,500	–	–	0.17%	43
2019 Q4	$4.61M	Hold	62,500	–	–	0.22%	39
2019 Q3	$2.64M	Hold	62,500	–	–	0.22%	39
2019 Q2	$4.47M	Hold	62,500	–	–	0.31%	34
2019 Q1	$4.74M	Hold	62,500	–	–	0.25%	38
2018 Q4	$4.23M	Hold	62,500	–	–	0.17%	38
2018 Q3	$5.36M	Hold	62,500	–	–	0.23%	39
2018 Q2	$6.98M	Hold	62,500	–	–	0.33%	38
2018 Q1	$13.1M	Hold	62,500	–	–	0.58%	26
2017 Q4	$13.8M	Buy	+62,500	New	+$14.8M	0.57%	26

Other funds holding PHXM

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Group One Trading

Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return